Oruka Therapeutics (ORKA) Profit After Tax Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -13.27% |
| Mar 31, 2024 | -3.84% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | 2.22% |
| Jun 30, 2023 | 6.90% |
| Mar 31, 2023 | 13.22% |
| Dec 31, 2022 | 22.49% |
| Sep 30, 2022 | 12.05% |
| Jun 30, 2022 | 10.64% |
| Mar 31, 2022 | 5.48% |
| Dec 31, 2021 | -5.99% |
| Sep 30, 2021 | -0.23% |
| Jun 30, 2021 | -4.42% |
| Mar 31, 2021 | -2.37% |
| Dec 31, 2020 | -10.10% |
| Sep 30, 2020 | 6.69% |
| Jun 30, 2020 | 13.69% |
| Mar 31, 2020 | 13.62% |
| Dec 31, 2019 | 14.03% |
| Sep 30, 2019 | 12.73% |
| Jun 30, 2019 | 9.80% |
| Mar 31, 2019 | 6.98% |
| Dec 31, 2018 | 12.76% |
| Sep 30, 2018 | 1.56% |
| Jun 30, 2018 | -12.03% |
| Mar 31, 2018 | -20.62% |
| Dec 31, 2017 | -37.95% |
| Sep 30, 2017 | -36.75% |
| Jun 30, 2017 | -36.96% |
| Mar 31, 2017 | -25.26% |
| Dec 31, 2016 | -21.09% |
| Sep 30, 2016 | -20.66% |
| Jun 30, 2016 | -72.43% |
| Mar 31, 2016 | -10.58% |
| Dec 31, 2015 | -14.71% |
| Sep 30, 2015 | -5.97% |
| Jun 30, 2015 | -3.68% |